SCHEMBL6767401

SCHEMBL6767401

N[C@@H](CC1COc2ccc(C(F)(F)F)cc2O1)C1CCN(c2ccccc2O)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 8/20 0.37
ADRA1A P35348 8/20 0.37
ADRA1B P35368 8/20 0.37
HTR1A P08908 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
HTR2C P28335 1/20 0.37
DRD3 P35462 1/20 0.37
GAA P10253 2/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 4/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
RECQL P46063 1/20 0.36
TRPV1 Q8NER1 2/20 0.35
LTA4H P09960 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6760337 0.86 ADRA1D (0.51) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL6760327 0.81 ADRA1D (0.44) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL6760338 0.81 ADRA1D (0.59) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL6760339 0.81 ADRA1D (0.59) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL7684365 0.76 ADRA1D (0.36) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL7684360 0.76 ADRA1D (0.36) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL6760336 0.69 ADRA1D (0.76) ADRA1DADRA1AADRA1BHTR1ADRD2
SCHEMBL909508 0.69 HTT (0.46) DRD2DRD4DRD3LMNAMEN1
SCHEMBL909936 0.69 HTT (0.46) DRD2DRD4DRD3LMNAMEN1
SCHEMBL909506 0.69 HTT (0.46) DRD2DRD4DRD3LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040039023-A1 Therapeutic agents KNOLL GMBH (DE) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039023-A1 Therapeutic agents AMY1A, PARK7, SNCA ADRA1D 16/4885ADRA1A 27/4885ADRA1B 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.